CXCL2/10/12/14 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma

• Published in: Bioscience reports 2021-06, Vol.41 (6)
• Main Authors: Lin, Tong, Zhang, E, Mai, Pei-Pei, Zhang, Ying-Zhao, Chen, Xiang, Peng, Li-Sheng
• Format: Article
• Language: English
• Subjects: Alternations; Angiogenesis; Bioinformatics; Biomarkers; Biomarkers, Tumor - genetics; Cancer; Carcinoma, Hepatocellular - genetics; Carcinoma, Hepatocellular - immunology; Carcinoma, Hepatocellular - pathology; Case-Control Studies; Chemokine CXCL10 - genetics; Chemokine CXCL12 - genetics; Chemokine CXCL2 - genetics; Chemokines; Chemokines, CXC - genetics; Correlation; Databases, Genetic; Datasets; Gene expression; Gene Expression & Regulation; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Gene set enrichment analysis; Genes; Genomics; Hepatocellular carcinoma; Humans; Immune system; Immunity; Immunology & Inflammation; Immunotherapy; Infiltration; Inflammation; Liver cancer; Liver Neoplasms - genetics; Liver Neoplasms - immunology; Liver Neoplasms - pathology; Lymphocytes; Medical prognosis; Metastases; Metastasis; Microenvironments; Prognosis; Proteins; RNA; Survival analysis; Toll-like receptors; Tumor Microenvironment - immunology; Tumor-infiltrating lymphocytes; Tumors
• ISSN: 0144-8463; 1573-4935
• DOI: 10.1042/BSR20204312

C-x-C motif chemokine ligands (CXCLs) are critical regulators of cancer immunity and angiogenesis, which affect disease progression and treatment responses. The character of each CXCL in the prognosis and immune infiltration of hepatocellular carcinoma (HCC) patients is unclear yet. Differentially expressed CXCLs between HCC and normal control were screened by Oncomine and GEPIA2. Genetic alternations of CXCLs in HCC were analyzed by cBioPortal. Clinicopathological relevance of CXCLs in HCC patients was analyzed using UALCAN. The prognostic value of CXCLs was evaluated using univariate and multivariate analyses. Correlations of CXCLs' expression with immune infiltration, chemokines and their receptors were assessed integrating TIMER, TISIDB, and GEPIA2. The co-expressed genes of CXCLs were discovered, and functional enrichment analysis was performed for them. CXCL9/10 was significantly higher expressed while CXCL2/12/14 was lower expressed in HCC than normal tissues, but they didn't show significant clinicopathological relevance in HCC patients. High-expression of CXCL2/10/12/14 indicated favorable outcomes of HCC patients. The expression of CXCL9/10/12/14 was significantly positively correlated with not only the infiltration and biomarkers' expression of various tumor-infiltrating immune cells but also the abundance of chemokines and their receptors. The co-expressed genes of the five CXCLs were extracellular components and regulated immune or inflammatory responses and signaling pathways of chemokine, Toll-like receptor and tumor necrosis factor might be involved. The present study proposed CXCL2/10/12/14 might predict outcomes of HCC patients and were extensively related with the immune microenvironment in HCC. It would be a prospective therapeutic strategy for HCC to enhance effective immunity surveillance through intervening in these CXCLs.